22.04.2021
Pharmasyntez Group of Companies increased its revenue by 43% in 2020
The Pharmasyntez Group of Companies has announced its financial results for 2020:
- the consolidated revenue increased by 43% and amounted to 32.6 billion RUB (36.4 billion RUB including VAT).
- the profit before interest payable, taxes and depreciation (EBITDA) for 2020 amounted to 6.7 billion RUB, which is 22% higher than in 2019
- EBITDA margin is 21%